Impact of Tafamidis and Optimal Background Treatment on Physical Performance in Patients With Transthyretin Amyloid Cardiomyopathy

Circulation Heart Failure
July 1, 2022
Cited by 36


Related Papers

No related papers found

Powered by citation graph analysis